Comparison of magnetic resonance spectroscopy and positron emission tomography in detection of tumor recurrence in posttreatment of glioma: A diagnostic meta-analysis.
It is important to distinguish between tumor recurrence and treatment effects in posttreatment patients with high-grade gliomas. Several imaging modalities have been reported in differentiating between tumor recurrence and treatment effects. However, there were no consistent conclusions between different studies. We performed a meta-analysis of 23 studies that compared the diagnostic values of fluorine-18-fluorodeoxyglucose ((18)F-FDG) and (11)C-methionine ((11)C-MET) PET (positron emission tomography) or PET/CT (computed tomography) and magnetic resonance spectroscopy (MRS) in predicting tumor recurrence of gliomas. The pooled estimated sensitivity, specificity, positive likelihood ratios, negative likelihood ratios and summary receiver operating characteristic curves of (18)F-FDG and (11)C-MET PET or PET/CT and MRS in detecting tumor recurrence were calculated. In conclusion, MRS is highly sensitive in the detection of tumor recurrence in glioma.(18)F-FDG PET or PET/CT is highly specific in recurrence diagnosis. (11)C-MET does not have noticeable advantage over (18)F-FDG. The current evidence shows no statistical difference between MRS and PET on the accuracy.
Department of Surgery, Shandong Cancer Hospital & Institute, Jinan, Shandong, China.
Xiaoyue
X
Wang
Xudong
X
Hu
Peng
P
Xie
Wanhu
W
Li
Xiaoling
X
Li
Li
L
Ma
D001932:Brain Neoplasms / Q000532:radiotherapy*; D005260:Female; D019788:Fluorodeoxyglucose F18 / Q000378:metabolism*; D005910:Glioma / Q000532:radiotherapy*; D006801:Humans; D009682:Magnetic Resonance Spectroscopy / Q000379:methods*; D009364:Neoplasm Recurrence, Local; D049268:Positron-Emission Tomography / Q000379:methods*
D019788:Fluorodeoxyglucose F18
glioma; magnetic resonance spectroscopy; meta-analysis; positron emission tomography; recurrence